These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 13830749)

  • 21. THE RISK OF SARCOMATOUS CHANGE AFTER IRON-DEXTRAN THERAPY.
    CHANDRA RK
    Indian J Pediatr; 1965 Feb; 32():75-7. PubMed ID: 14281290
    [No Abstract]   [Full Text] [Related]  

  • 22. IRON-DEXTRAN AND VITAMIN B COMPLEX FOR THE TREATMENT OF ANEMIA IN ADULT SHEEP.
    KIESEL GK; CLARK CH
    J Am Vet Med Assoc; 1964 Sep; 145():452-5. PubMed ID: 14215376
    [No Abstract]   [Full Text] [Related]  

  • 23. [3. COLLATERAL EFFECTS OF THE INTRAMUSCULAR ADMINISTRATION OF IRON-DEXTRAN].
    BERGAMI
    Ann Sanita Pubblica; 1964; 25():1182-5. PubMed ID: 14260486
    [No Abstract]   [Full Text] [Related]  

  • 24. REACTIONS TO INTRAVENOUS IRON DEXTRAN.
    SEFTEL HC
    Br Med J; 1965 Mar; 1(5435):657. PubMed ID: 14245189
    [No Abstract]   [Full Text] [Related]  

  • 25. MORPHOLOGICAL EFFECTS OF IRON-DEXTRAN ON FOWL FIBROCYTES IN VITRO.
    TURNER CJ
    Br J Cancer; 1963 Dec; 17(4):731-7. PubMed ID: 14111613
    [No Abstract]   [Full Text] [Related]  

  • 26. CARCINOGENIC RISK OF IRON-DEXTRAN.
    GIUFFRIDA G; CONDORELLI M; FILOCAMO G; MIGLIAU G; PUGLIESE F; BASILE U
    Br Med J; 1964 Jun; 1(5398):1583-4. PubMed ID: 14134484
    [No Abstract]   [Full Text] [Related]  

  • 27. [THE EFFECT OF IRON INJECTIONS IN ANIMAL EXPERIMENTS].
    GOLBERG L
    Arzneimittelforschung; 1963 Nov; 13():939-45. PubMed ID: 14210427
    [No Abstract]   [Full Text] [Related]  

  • 28. IRON STORAGE IN N-2-FLUORENYLACETAMIDE-INDUCED HEPATIC INJURY. ELECTRON MICROSCOPIC OBSERVATIONS FOLLOWING THE INJECTION OF IRON-DEXTRAN.
    KENT G; MINICK OT; VOLINI FI; ORFEI E; DELAHUERGA J
    Lab Invest; 1963 Nov; 12():1102-12. PubMed ID: 14083321
    [No Abstract]   [Full Text] [Related]  

  • 29. IRON-DEXTRAN complex.
    J Am Med Assoc; 1958 Mar; 166(12):1482-3. PubMed ID: 13513389
    [No Abstract]   [Full Text] [Related]  

  • 30. Toxicologic, hematologic, and growth studies on pigs given hydrogenated iron-dextran intramuscularly.
    HERIN RA
    J Am Vet Med Assoc; 1962 Nov; 141():1062-3. PubMed ID: 13953942
    [No Abstract]   [Full Text] [Related]  

  • 31. IRON-DEXTRAN AND SARCOMATA.
    GILLIE A
    Br Med J; 1964 Jul; 2(5401):119-21. PubMed ID: 14147762
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current knowledge of the presumed carcinogenic power of the iron-dextran complex (Imferon)].
    LAYRISSE M
    Rev Obstet Ginecol Venez; 1961; 21():307-13. PubMed ID: 14463059
    [No Abstract]   [Full Text] [Related]  

  • 33. [TREATMENT OF ANEMIC DONORS WITH IRON-DEXTRAN].
    TERAHATA K
    Iryo; 1964 Jul; 18():487-8. PubMed ID: 14196274
    [No Abstract]   [Full Text] [Related]  

  • 34. [STUDIES ON ABSORPTION AND EXCRETION OF DRUGS. I. FE-59 LABELED IRON DEXTRAN AND FE-59 LABELED IRON FUMARATE].
    IWAKI R; TAMURA Y
    Nihon Yakurigaku Zasshi; 1964 Sep; 60():435-41. PubMed ID: 14271234
    [No Abstract]   [Full Text] [Related]  

  • 35. THE TREATMENT OF IRON-DEFICIENCY ANEMIA WITH INTRAVENOUS IRON DEXTRAN.
    MARCHASIN S; WALLERSTEIN RO
    Blood; 1964 Mar; 23():354-8. PubMed ID: 14130446
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of intestinal tumors in rats by dextran sulfate sodium.
    Hirono I; Kuhara K; Hosaka S; Tomizawa S; Golberg L
    J Natl Cancer Inst; 1981 Mar; 66(3):579-83. PubMed ID: 6162992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on iron-dextran complex.
    KARLEFORS T; NORDEN A
    Acta Med Scand Suppl; 1958; 342():1-54. PubMed ID: 13626533
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recommendations for testing and evaluation of drugs as to carcinogenicity].
    Schramm T; Schwabe K; Gibel W
    Arch Geschwulstforsch; 1971; 37(1):53-65. PubMed ID: 4102700
    [No Abstract]   [Full Text] [Related]  

  • 39. [Iron-dextran complex in the treatment of iron deficiency anemia].
    ISAK G
    Harefuah; 1960 Aug; 59():116-7. PubMed ID: 13717946
    [No Abstract]   [Full Text] [Related]  

  • 40. Iron-induced myocardial injury: an alarming side effect of superparamagnetic iron oxide nanoparticles.
    Shen Y; Huang Z; Liu X; Qian J; Xu J; Yang X; Sun A; Ge J
    J Cell Mol Med; 2015 Aug; 19(8):2032-5. PubMed ID: 26041641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.